Both in Pharmaceuticals
GRI Bio vs Jupiter Neurosciences
Over the past year GRI returned −97.0% and JUNS returned −98.0%; their daily moves had a correlation of 0.03.
GRI −97.0% JUNS −98.0%Growth of $1, one year, split-adjusted
| Metric | GRI | JUNS |
|---|---|---|
| Price | $1.63 | $2.50 |
| Market cap | $3.6M | $3.3M |
| Today | +2.85% | −5.30% |
| 1 month | −18.8% | −3.1% |
| 6 months | −27.1% | −90.7% |
| Year to date | −76.5% | −96.7% |
| 1 year | −97.1% | −98.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 86.9% |
| Net margin | — | −9380.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 51.0× |
| Net cash | $10.9M | -$6.6K |
| Dividend yield | — | — |
| Volatility (60d) | 134.4% | 1,269.5% |
| Short % of float | 3.0% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).